SU858563A3 - Method of preparing quinazoline derivatives or their salts - Google Patents

Method of preparing quinazoline derivatives or their salts Download PDF

Info

Publication number
SU858563A3
SU858563A3 SU762386166A SU2386166A SU858563A3 SU 858563 A3 SU858563 A3 SU 858563A3 SU 762386166 A SU762386166 A SU 762386166A SU 2386166 A SU2386166 A SU 2386166A SU 858563 A3 SU858563 A3 SU 858563A3
Authority
SU
USSR - Soviet Union
Prior art keywords
group
formula
salts
quinazoline derivatives
groups
Prior art date
Application number
SU762386166A
Other languages
Spanish (es)
Russian (ru)
Inventor
Кристофер Данилевич Джон
Гарт Эванс Антони
Лесли Хэм Алан
Томсон Колин
Original Assignee
Пфайзер Корпорейшн (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Корпорейшн (Фирма) filed Critical Пфайзер Корпорейшн (Фирма)
Application granted granted Critical
Publication of SU858563A3 publication Critical patent/SU858563A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento para preparar derivados de quinazolina, de fórmula: **(Fórmula)** en la que (i) R1 es un átomo de hidrógeno o un grupo alquilo inferior; (R2)n representa de 1 a 3 sustituyentes opcionales, siendo cada R2 un átomo de hidrógeno o un grupo hidroxi o alcoxi inferior y siendo n de 1 a 3, o constituyendo dos cualquiera de las mitades R2 un grupo metilendioxi o etilendioxi unido a posiciones adyacentes del anillo A; (ii) X representa - (CH2)p-en donde p es 1 a 3; (iii) y está unido a la posición 3 ó 4 del anillo C y representa un grupo de fórmula -Z-CO-NHR6 ó -Z-CS-NHR6.Process for preparing quinazoline derivatives, of the formula: (Formula) ** wherein (i) R 1 is a hydrogen atom or a lower alkyl group; (R2) n represents from 1 to 3 optional substituents, each R2 being a hydrogen atom or a hydroxy or lower alkoxy group and n being from 1 to 3, or any two of the R2 halves constituting a methylenedioxy or ethylenedioxy group attached to positions adjacent to ring A; (ii) X represents - (CH2) p- wherein p is 1 to 3; (iii) and is attached to the 3 or 4 position of the C ring and represents a group of formula -Z-CO-NHR6 or -Z-CS-NHR6.

Description

(54) СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ХИНАЗОЛИНА Изобретение относитс  к способу получени  новых производных хинаэоли на формулы где У - NHCONR R,z, NHC S NR R, или CHaCONR R группы, где R низша  алкильна  группа, Су- оксиалкильна  группа , алкил, алкенил или алкинил , замещенные пиридилом. RJ,- водород, и R совме но с атомом азота, к которо му они присоединены, образу ют пиперидиновое кольцо, X - группа СН2.-СН или, когда V-CHACON ; группа, то X - группа - СН С. , или их солей, которые обладают биологической активнос тью. Известен способ взаимодействи  изоцианатов с аминами ij. Цель изобретени  - способ получе ни  новых производных хиназолина, которые могут найти применение в ка ИЛИ ИХ СОЛЕЙ честве биологически активных соединений . Поставленна  цель достигаетс  способом получени  соединений формулы 1, заключающемс  в том, что хинлэолин формулы группьа NCO, NCS или CftjCOQ, причем Q представл ет собой легко отщепл емую группу, такую как хлор, бром или О -о-а. X - , или когда Z пред ставл ет собой CH,.COQ, то X - , подвергают взаимодействию с соедине ннем формулы NH, где ft-ji имеют указанные значени  в среде инертного растворител  при комнатной температуре и вьадел ют целевой продукт в свободном виде ил в виде соли. Фармацевтически применимые соли присоединени  кислот соединений фор мулы 1 представл ют собой такие сое динени , которые получают из кислот содержащие фармацевтически применимые анионы, например, такие как гид рохлорид, гидробромид, гидрооксид, сульфат или бисульфат, фосфат или .кислый фосфат, ацетат, малеат, фум рат, оксалат, лактат, гартрат, цитрат , глюконат, сахарат и п-голуилсульфонат . Пример. 1/ДССД и N-гидроксисукцннамид 2(СНз)СН2) CH,COf{}iiCHg),C CH-COM),CHj4- (4-карбоксиметил)-1,2, 3,6-тет рагидролирид-1-ил -6,7-диметоксихимазолин гидрохлорид (0,92 г), полученный гидролизом эфира в сухом хлороформе (20 мл), содержащий триэтиламин (0,3 г), перемешивают до полного завершени  реакции. Дициклогексил карбодиимид (0,63 г и N-гидроксисукцинимид (0,35 г) добавл ют с последующим сто нием в течение ночи, в результате чего осаждаетс  более твердое вещество н-бутиламин (0,22 г), добавл ют к смеси и снова оставл ют сто ть 5 ч, после чего раствор фильтруют, промывают водой, и органическую фазу выпаривают в вакууме досуха. Остаток обрабатывают ацетонитрилом, фильтру|от, и Фильтоат обрабатывают эфирным раствором НС1 до образовани  кисло ,ты. Осадившийс  гидрохлорид 4-.И-Н-бутилкарбамоилметил )-1,2,3,6-тетрадидропирид-1-ил -6,7-диметоксихин-; азолин перекристаллизовывают из эта ,нола. Выход 340 мг при 1 . в виде полугидрата., Вычислено, %: С 58,65, Н 7,0, N 13,0. C2i%gN 03-l/2 НгО Найдено, %: С , Н 6,7; N 12,9. Примеры 2-7. Получение производных соединений формулы Результаты представлены -в таблице.(54) METHOD FOR PRODUCING HINAZOLINE DERIVATIVES The invention relates to a method for producing new quinae derivatives of the formulas where Y is NHCONR R, z, NHC S NR R, or CHaCONR R groups where R is a lower alkyl group, a hydroxyalkyl group, an alkyl, alkenyl or quinil, substituted pyridyl. RJ, is hydrogen, and R together with the nitrogen atom to which they are attached form a piperidine ring, X is the group CH2. —CH or when V is CHACON; the group, then the X — group — CH. S., or their salts, which possess biological activity. There is a method of reacting isocyanates with amines ij. The purpose of the invention is a method for the preparation of new quinazoline derivatives, which can be used in OR THEIR SALT as biologically active compounds. The objective is achieved by a process for the preparation of compounds of formula 1, namely, quinoline of the formula NCO, NCS or CftjCOQ, with Q being an easily removable group such as chlorine, bromine or O-o-a. X -, or when Z is CH, .COQ, then X - is reacted with a compound of formula NH, where ft-ji have the specified values in an inert solvent at room temperature and implant the desired product in free form. in the form of salt. The pharmaceutically applicable acid addition salts of the compounds of Formula 1 are those which are derived from acids containing pharmaceutically applicable anions, such as hydrochloride, hydrobromide, hydroxide, sulfate or bisulfate, phosphate or phosphate, acetate, maleate, fum rat, oxalate, lactate, gartrat, citrate, gluconate, saharat and p-goluylsulfonat. Example. 1 / DSSD and N-hydroxysuccinnamide 2 (CH3) CH2) CH, COf {} iiCHg), C CH-COM), CHj4- (4-carboxymethyl) -1,2, 3,6-tetrahydrolirid-1-yl - 6,7-dimethoxychimazoline hydrochloride (0.92 g), obtained by hydrolysis of ether in dry chloroform (20 ml) containing triethylamine (0.3 g), is stirred until the reaction is complete. Dicyclohexyl carbodiimide (0.63 g and N-hydroxysuccinimide (0.35 g) is added, followed by standing overnight, resulting in more solid n-butylamine (0.22 g) precipitating, added to the mixture and again left to stand for 5 hours, then the solution is filtered, washed with water, and the organic phase is evaporated in vacuo to dryness. The residue is treated with acetonitrile, filtered, and the Filtoate is treated with ethereal HCl to form an acidic acid. The precipitated hydrochloride 4-I. N-butylcarbamoylmethyl) -1,2,3,6-tetradidropyrid-1-yl-6,7-dimethoxyquin-; Azoline is recrystallized from eta, nola. Exit 340 mg at 1. as a hemihydrate., Calculated,%: C 58.65, H 7.0, N 13.0. C2i% gN 03-l / 2 HgO Found;%: C, H 6.7; N 12.9. Examples 2-7. Obtaining derivatives of compounds of the formula The results are presented in the table.

2/ NHCONH( (СНз) 4-Положег-2 / NHCONH ((CH3) 4-Put-

NHCON NHCON

То жеДигидрохло- 136-201 53,39The same Dihydrochlo- 136-201 53.39

(53,87(53.87

-NHCONH(CH.2) ОН-NHCONH (CH.2) OH

Свободное основание NHCONH(CH,)2 .Свободное -пиридил основаниеFree base NHCONH (CH,) 2. Free-pyridyl base

Свободное Free

NHCONH-CHj CHsCHj, основаниеNHCONH-CHj CHsCHj, base

6,56 13, 6,68 13,31)6.56 13, 6.68 13.31)

6,61 6.61

14,8214.82

15,54) 6,4315.54) 6.43

131-145 59,54 7,24 17,36 (58,96 7,84 16,97)131-145 59.54 7.24 17.36 (58.96 7.84 16.97)

211-214 61,446,78 18,85211-214 61,446,78 18,85

(61,iJ 6,81 18,85) Монотертрат,122-135 53,62 ( 53,39 199-201 63,29 6,47 19,25 (63,26 6,37 18,96)(61, iJ 6.81 18.85) Monotertrate, 122-135 53.62 (53.39 199-201 63.29 6.47 19.25 (63.26 6.37 18.96)

NHCONHCH C S СНNHCONHCH C S CH

МоногидратMonohydrate

197-190 58,90 (59,35197-190 58.90 (59.35

Claims (1)

Формула изобретени  Способ получени  производных хиназолина формулы 1The invention The method of obtaining quinazoline derivatives of the formula 1 Г tf-X-1G tf-X-1 2 - группы NCO,NCS или СН COQ,npHQ представл ет собой легко отщепл егруппу , такую как хлор, бром2 - NCO, NCS or CH COQ, npHQ groups are easily removed, such as chlorine, bromine O-N(D ;ON (D; О где у - NHCONR jR NHCSNR R2ИЛИ CHjiCONR Rg группы, где R низша  алкильна  группа С -С оксиалкильна  группа, алкил, алкенил, или алкинил, замещенные пиридилом; ft - -водород, и R совместно с атомом азота, к которому они присоединены, образуют пиперидиновое кольцо X -группа CHi-CH или, когда RZ, то X - группа .-СН-С , или их солей, отличающийс  тем, что хиназолин формулы II ,«: X - СН„-СН, Й или когда 2 представэй CHjCOQ, то X - , подвергают взаимодействию с соединением формулы III - где R и R 2 имеют указанное значени  в среде инертного растворител  при комнатной температуре и выщел ют целевой продукт в свободномвиде или в виде солц. Источники информации, прин тые во внимание при экспертизе 1. Вейганд-Хильгетаг. Методы эксперимента в органической химии. М., Хими , 1968, с. 377,O where y is NHCONR jR NHCSNR R2 OR CHjiCONR Rg groups, where R is a lower alkyl group C-C oxyalkyl group, alkyl, alkenyl, or alkynyl, substituted with pyridyl; ft is hydrogen, and R together with the nitrogen atom to which they are attached form a piperidine ring X, a CHi-CH group, or, when RZ, then X is a.-CH-C group or their salts, characterized in that quinazoline Formula II, ": X - CH" -CH, Y, or when 2 represents CHjCOQ, then X - is reacted with a compound of formula III - where R and R 2 have the indicated value in an inert solvent at room temperature and leach out in free form or in the form of solts. Sources of information taken into account in the examination 1. Weigand-Hilgetag. Experimental methods in organic chemistry. M., Himi, 1968, p. 377,
SU762386166A 1974-07-25 1976-08-02 Method of preparing quinazoline derivatives or their salts SU858563A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3280574 1974-07-25

Publications (1)

Publication Number Publication Date
SU858563A3 true SU858563A3 (en) 1981-08-23

Family

ID=10344259

Family Applications (5)

Application Number Title Priority Date Filing Date
SU7502162232A SU578874A3 (en) 1974-07-25 1975-07-25 Method of preparing quinozaline derivatives or their salts
SU762386166A SU858563A3 (en) 1974-07-25 1976-08-02 Method of preparing quinazoline derivatives or their salts
SU762388319A SU613723A3 (en) 1974-07-25 1976-08-10 Method of obtaining quinazoline derivatives or salts thereof
SU762388320A SU625606A3 (en) 1974-07-25 1976-08-10 Method of producing quinazoline or their salts
SU762388318A SU634671A3 (en) 1974-07-25 1976-08-10 Method of obtaining quinazoline derivatives or salts thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SU7502162232A SU578874A3 (en) 1974-07-25 1975-07-25 Method of preparing quinozaline derivatives or their salts

Family Applications After (3)

Application Number Title Priority Date Filing Date
SU762388319A SU613723A3 (en) 1974-07-25 1976-08-10 Method of obtaining quinazoline derivatives or salts thereof
SU762388320A SU625606A3 (en) 1974-07-25 1976-08-10 Method of producing quinazoline or their salts
SU762388318A SU634671A3 (en) 1974-07-25 1976-08-10 Method of obtaining quinazoline derivatives or salts thereof

Country Status (7)

Country Link
AT (1) AT344178B (en)
BE (1) BE831654A (en)
CS (1) CS192549B2 (en)
ES (4) ES439690A1 (en)
HU (1) HU174961B (en)
PL (6) PL103789B1 (en)
SU (5) SU578874A3 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070004763A1 (en) * 2005-06-10 2007-01-04 Nand Baindur Aminoquinoline and aminoquinazoline kinase modulators

Also Published As

Publication number Publication date
ES455985A1 (en) 1978-06-16
SU578874A3 (en) 1977-10-30
PL99427B1 (en) 1978-07-31
ES455984A1 (en) 1978-06-01
PL193423A1 (en) 1978-04-24
AT344178B (en) 1978-07-10
PL103797B1 (en) 1979-07-31
SU634671A3 (en) 1978-11-25
PL103791B1 (en) 1979-07-31
PL103798B1 (en) 1979-07-31
PL193421A1 (en) 1978-04-24
ES439690A1 (en) 1977-07-01
PL193422A1 (en) 1978-06-05
HU174961B (en) 1980-04-28
ATA525275A (en) 1977-11-15
SU625606A3 (en) 1978-09-25
SU613723A3 (en) 1978-06-30
PL103789B1 (en) 1979-07-31
CS192549B2 (en) 1979-08-31
BE831654A (en) 1976-01-23
PL193420A1 (en) 1978-04-24
PL193419A1 (en) 1978-04-24
ES455986A1 (en) 1978-06-01
PL104615B1 (en) 1979-08-31

Similar Documents

Publication Publication Date Title
US2627491A (en) Penicillin salts of substituted alkylene diamines
SU1428199A3 (en) Versions of method of producing derivatives of 2,2,3-iminobisethanol or acid-additive salts thereof,or stereochemical isomeric forms thereof
US4315007A (en) 4-Amino-6,7-dimethoxyquinazol-2-yl alkylenediamines
US3972932A (en) Novel 2,6-disubstituted phenyl-aminoguanidine compounds
SU858563A3 (en) Method of preparing quinazoline derivatives or their salts
US5155116A (en) Medicinal oxazolopyridine compounds
EP0179408B1 (en) Amidoalkyl melamines and aminoalkyl melamines, and process for their preparation
DE3122784A1 (en) "N (ARROW HIGH) 6 (ARROW HIGH) SUBSTITUTED ADENOSINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME"
CA1118445A (en) N,n'-[bis(n-cyanoguanyl)] crystamine derivatives
EP0033789B1 (en) 2-alpha-methyl-dopaminimino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, its salts, and a process for preparation thereof
US4120858A (en) 14-Substituted vincanes
IL25315A (en) O-(2-guanidino-ethyl)-oximes
DE2114884A1 (en) Basically substituted derivatives of 1 (2H) -phthalazinone
US3929803A (en) Aryl carboxylic acids
US2328594A (en) Compo und
SU493067A3 (en) The method of obtaining phenylimidazolidinone
JPH0625191B2 (en) 1- [2- (phenylmethyl) phenylphenylperazine compound, its production method and pharmaceutical composition
US4290971A (en) Method of preparing 2-(phenylamino)-imidazolines-(2)
CS207661B2 (en) Method of making the 1-phenylethanolamin derivatives
CA1041098A (en) 1-(3-(naphthyl-1-yl-oxy)-propyl)-piperazine derivatives
GB2023574A (en) N-cyano-azomethine derivatives
US3278542A (en)
SU694497A1 (en) 1 -adamantylammonium beta -chloroethyloxaminate exhibiting adrenoblocking activity
US3252976A (en) Process for making 2-secondary and tertiary amino-1-phenyl-ethane thiols
IL34882A (en) Nitrofuryl-aminoalkoxy-pyrimidine